FLUERE Trademark

Trademark Overview


On Thursday, March 7, 2024, a trademark application was filed for FLUERE with the United States Patent and Trademark Office. The USPTO has given the FLUERE trademark a serial number of 98439198. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Friday, January 3, 2025. This trademark is owned by CIATRIX, Inc.. The FLUERE trademark is filed in the Medical Instrument Products category with the following description:

medical devices for use in treating neurodegenerative diseases, neurocognitive diseases, Alzheimer's disease, symptom of stroke, symptom of traumatic brain injury, cerebrospinal fluid dynamics dysfunction, neuroinflammation, and increased intracranial fluid; therapeutic devices using cerebrospinal fluid motion, cerebrospinal fluid pressure changes, spinal motion, respiratory inhalation and exhalation, improved performance of lymphatic system, improved performance of glymphatic system, improved posture, improved glymphatic clearance, improved drug delivery in cerebrospinal fluid, improved drug delivery in blood, and lowering brain wave activity to provide relief from neurodegenerative diseases, neurocognitive diseases, Alzheimer's disease, symptom of stroke, symptom of traumatic brain injury, cerebrospinal fluid dynamics dysfunction, neuroinflammation, and increased intracranial fluid; and diagnostic devices, namely, medical diagnostic apparatus for testing cerebrospinal fluid dynamics
fluere

General Information


Serial Number98439198
Word MarkFLUERE
Filing DateThursday, March 7, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateFriday, January 3, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicesmedical devices for use in treating neurodegenerative diseases, neurocognitive diseases, Alzheimer's disease, symptom of stroke, symptom of traumatic brain injury, cerebrospinal fluid dynamics dysfunction, neuroinflammation, and increased intracranial fluid; therapeutic devices using cerebrospinal fluid motion, cerebrospinal fluid pressure changes, spinal motion, respiratory inhalation and exhalation, improved performance of lymphatic system, improved performance of glymphatic system, improved posture, improved glymphatic clearance, improved drug delivery in cerebrospinal fluid, improved drug delivery in blood, and lowering brain wave activity to provide relief from neurodegenerative diseases, neurocognitive diseases, Alzheimer's disease, symptom of stroke, symptom of traumatic brain injury, cerebrospinal fluid dynamics dysfunction, neuroinflammation, and increased intracranial fluid; and diagnostic devices, namely, medical diagnostic apparatus for testing cerebrospinal fluid dynamics

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, March 7, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCIATRIX, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLEWES, DE 19958

Trademark Events


Event DateEvent Description
Thursday, March 7, 2024NEW APPLICATION ENTERED
Monday, July 22, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 20, 2024ASSIGNED TO EXAMINER
Tuesday, October 1, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 1, 2024NON-FINAL ACTION WRITTEN
Thursday, January 2, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 2, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 3, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 1, 2024NON-FINAL ACTION E-MAILED